Mingzhen Zhou

321 Zhongshan Road
Nanjing, 210008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

LAG3-centered multiplex immune profiling as a prognostic biomarker in hepatocellular carcinoma patients receiving Anti-PD-1 antibodies plus lenvatinib therapy.

LAG3-centered multiplex immune profiling as a prognostic biomarker in hepatocellular carcinoma patients receiving Anti-PD-1 antibodies plus lenvatinib therapy.

Journal: Frontiers in oncology

Published: May 12, 2026

Multidimensional analysis of tumour immune microenvironment in HCC: prognostic significance and implications for immunotherapy.

Multidimensional analysis of tumour immune microenvironment in HCC: prognostic significance and implications for immunotherapy.

Journal: Cancer immunology, immunotherapy : CII

Published: January 13, 2026

Intracavitary infusion of FOLactis Lactobacillus leads to disappearance of MPE in patient with advanced lung adenocarcinoma.

Intracavitary infusion of FOLactis Lactobacillus leads to disappearance of MPE in patient with advanced lung adenocarcinoma.

Journal: Discover oncology

Published: June 04, 2025

Multiplex immunohistochemistry to explore the tumor immune microenvironment in HCC patients with different GPC3 expression.

Multiplex immunohistochemistry to explore the tumor immune microenvironment in HCC patients with different GPC3 expression.

Journal: Journal of translational medicine

Published: August 23, 2024

Circulating Biomarkers Predict Immunotherapeutic Response in Hepatocellular Carcinoma Using a Machine Learning Method.

Circulating Biomarkers Predict Immunotherapeutic Response in Hepatocellular Carcinoma Using a Machine Learning Method.

Journal: Journal of hepatocellular carcinoma

Published: June 04, 2024

CT radiomics-based biomarkers can predict response to immunotherapy in hepatocellular carcinoma.

CT radiomics-based biomarkers can predict response to immunotherapy in hepatocellular carcinoma.

Journal: Scientific reports

Published: March 02, 2024

KK-LC-1, a biomarker for prognosis of immunotherapy for primary liver cancer.

KK-LC-1, a biomarker for prognosis of immunotherapy for primary liver cancer.

Journal: BMC cancer

Published: December 20, 2023

A novel nomogram for predicting the prognosis of hepatocellular carcinoma patients following immune checkpoint inhibitors treatment beyond progression: a single center study based on Chinese population.

A novel nomogram for predicting the prognosis of hepatocellular carcinoma patients following immune checkpoint inhibitors treatment beyond progression: a single center study based on Chinese population.

Journal: Hepatobiliary surgery and nutrition

Published: December 07, 2023

An Advanced Intrahepatic Cholangiocarcinoma Patient Benefits from Personalized Immunotherapy.

An Advanced Intrahepatic Cholangiocarcinoma Patient Benefits from Personalized Immunotherapy.

Journal: Inflammation

Published: November 30, 2023

Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy.

Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy.

Journal: Journal of hepatocellular carcinoma

Published: November 29, 2023

A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer.

A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer.

Journal: Clinical & translational immunology

Published: October 12, 2023

Survival benefit and biomarker of PD-1 inhibitor combination therapy in first-line of advanced biliary tract cancer: A retrospective study.

Survival benefit and biomarker of PD-1 inhibitor combination therapy in first-line of advanced biliary tract cancer: A retrospective study.

Journal: Cancer medicine

Published: April 04, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026